Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications

被引：1
|
作者：
Low, En Xian Sarah [1 ]
Wang, Yen-Po [1 ,3 ]
Lu, Ching-Liang [1 ,2 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
Cirrhosis; Proton pump inhibitors; Hepatocellular carcinoma; Hepatic decompensation; Spontaneous bacterial peritonitis;
D O I：
10.1007/s10620-023-08153-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [1] Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications
    En Xian Sarah Low
    Yen-Po Wang
    Ching-Liang Lu
    Digestive Diseases and Sciences, 2024, 69 : 7 - 9
  • [2] Risks of Proton Pump Inhibitors for Patients With Cirrhosis: The Controversy Remains
    de Mattos, Angelo Zambam
    da Silva Miozzo, Suelen Aparecida
    Tovo, Cristiane Valle
    de Mattos, Angelo Alves
    HEPATOLOGY, 2017, 66 (01) : 295 - 296
  • [3] The Indications, Applications, and Risks of Proton Pump Inhibitors
    Moessner, Joachim
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (27-28): : 477 - +
  • [4] Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks
    Gasser El-Azab
    Current Gastroenterology Reports, 2024, 26 (12) : 323 - 334
  • [5] Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites
    Dam, Gitte
    Vilstrup, Hendrik
    Andersen, Per Kragh
    Bossen, Lars
    Watson, Hugh
    Jepsen, Peter
    LIVER INTERNATIONAL, 2019, 39 (03) : 514 - 521
  • [6] Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors
    Zerr, Beth
    Vazquez, Alejandro
    Erstad, Brian L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (15) : 967 - 973
  • [7] Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis
    Garcia-Martinez, Irma
    Frances, Ruben
    Zapater, Pedro
    Gimenez, Paula
    Gomez-Hurtado, Isabel
    Moratalla, Alba
    Lozano-Ruiz, Beatriz
    Bellot, Pablo
    Gonzalez-Navajas, Jose M.
    Such, Jose
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 147 - 154
  • [8] Safe use of proton pump inhibitors in patients with cirrhosis
    Weersink, Rianne A.
    Bouma, Margriet
    Burger, DavidM.
    Drenth, Joost P. H.
    Harkes-Idzinga, S. Froukje
    Hunfeld, Nicole G. M.
    Metselaar, Herold J.
    Monster-Simons, Margje H.
    van Putten, Sandra A. W.
    Taxis, Katja
    Borgsteede, Sander D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (08) : 1806 - 1820
  • [9] Comparative Study of Spontaneous Bacterial Peritonitis in Cirrhosis Patients Managed with and without Proton Pump Inhibitors
    Hayat, Muhammad Khizer
    Shah, Zahid Hussain
    Hayat, Muhammad Fahr
    Imran, Muhammad Yasir
    Qureshi, Irshad Hussain
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (02): : 598 - 601
  • [10] Editorial: proton pump inhibitors in cirrhosis
    Sutherland, D.
    Stanley, A. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (06) : 592 - 592
12345